Cost per BRCA1 mutation detected among members of high-risk families with a living cancer-affected relative or stored sample of their blood/DNA has been estimated to range between £74 [£90] (Eccles et al, 1998) and €6881.70 (£4328) (Sevilla et al, 2002). This evidence concerns the gene BRCA1 and cancer.